The global Plant Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
Plant vaccines, also known as plant-based vaccines, are a type of biotechnology that involves using plants to produce vaccines against various diseases. This approach is different from traditional methods of producing vaccines, which typically involve growing microbes or animal cells in culture. Plant vaccines work by introducing a gene encoding a specific part of a pathogen's antigen, such as a protein, into the plant's genome. As the plant grows, it produces the antigen, which triggers an immune response in the human or animal host that consumes it. This immune response is similar to the response that occurs when a traditional vaccine is administered.
Market Segmentation
Segmentation by Type:
- Transgenic
- Non-GMO
Segmentation by Application:
- Hospital
- Institute
- Others
Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage:
- Pharmaceutical Technology
- Merck
- Pfizer
Key Questions Addressed in this Report:
- What is the 10-year outlook for the global Plant Vaccine market?
- What factors are driving Plant Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Plant Vaccine market opportunities vary by end market size?
- How does Plant Vaccine break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market